Page last updated: 2024-11-07

metaraminol and Lung Diseases

metaraminol has been researched along with Lung Diseases in 2 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Lung Diseases: Pathological processes involving any part of the LUNG.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DEJONG, RH1
JASMIN, G1

Other Studies

2 other studies available for metaraminol and Lung Diseases

ArticleYear
ARTERIAL CARBON DIOXIDE AND OXYGEN TENSIONS DURING SPINAL BLOCK.
    JAMA, 1965, Mar-01, Volume: 191

    Topics: Anesthesia, Conduction; Anesthesia, Obstetrical; Anesthesia, Spinal; Blood Gas Analysis; Carbon Diox

1965
CARDIAC, AORTIC AND PULMONARY LESIONS INDUCED BY VASOPRESSORS.
    Vascular diseases, 1965, Volume: 2

    Topics: Aortic Diseases; Blood Chemical Analysis; Calcinosis; Heart Diseases; Histocytochemistry; Hypercalce

1965